Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/physique/design-of-nanostructures-for-theranostics-applications/descriptif_3777775
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3777775

Design of Nanostructures for Theranostics Applications Pharmaceutical Nanotechnology Series

Langue : Anglais

Coordonnateur : Grumezescu Alexandru Mihai

Couverture de l’ouvrage Design of Nanostructures for Theranostics Applications

Design of Nanostructures for Theranostics Applications focuses on the theranostics applications of nanostructures. In particular, multifunctional nanoparticles for diagnostics and treatment of different diseases, including those relating to the blood-brain barrier, are discussed in detail. Chapters explore different type of nanostructures, covering design, fabrication, functionalization and optimization, helping readers obtain the desired properties. Written by a diverse range of international academics, this book is a valuable reference resource for those working in both nanoscience and the pharmaceutical industry.

1. Multifunctional nanoparticles for successful targeted drug delivery and diagnostics across the blood-brain barrier
2. Trastuzumab drug delivery systems for Magnetic Resonance detection
3. A novel approach for drug targeting: core-shell type lipid-polymer hybrid nanocarriers
4. Multifunctional core-shell polymeric and hybrid nanoparticles as anticancer nanomedicines
5. Multifunctional Core Shell Nanostructures as Theranostics
6. Prospects of precision therapy and imaging of glioblastoma in vivo using quantum dots
7. Mesoporous silica nanoparticles as drug carrier for cancer therapy and bioimaging
8. Current approaches in breast cancer targeting pharmaceuticals
9. Novel multifunctional nano-carrier mediated co-delivery for targeting and treatment of prostate cancer
10. Nanoparticles and their promising applications in therapeutics and diagnostics of various neurological disorders
11. Conventional and current imaging techniques in cancer research and clinics
12. Synthetic microbial ecology and nanotechnology for production of taxol and its precursors: a step towards sustainable production of cancer therapeutics
13. Polymeric and lipid-based systems for controlled drug release: an engineering point of view
14. Mercaptosuccinic Acid Capped CdTe/CdS/ZnS nanoparticles Core-Double Shell Quantum Dots: Structural Optical Imaging and Cytotoxic Assessment on Normal and Cancer Cells
15. Quantum Dots in Pharmaceutical Sciences
16. Liposomes and Micelles as Lipid Based Nanocarriers for Diagnostic and Imaging Purposes
17/ Dendrimer-drug conjugates: synthesis, characterization and application in anticancer drug delivery
Dr. Grumezescu is Assistant Professor at the Department of Science and Engineering of Oxide Materials and Nanomaterials, in the Faculty of Applied Chemistry and Materials Science, with a second affiliation to the Faculty of Medical Engineering, at the Politehnica University of Bucharest in Romania. He is an experienced and oft-published researcher and editor in the field of nano and biomaterials, and he is the Editor-in-Chief of three journals: Biointerface Research in Applied Chemistry, Letters and Applied NanoBioScience, and Biomaterials and Tissue Engineering Bulletin. He also serves as editor or guest editor for several notable journals. Dr. Grumezescu has published 150 peer-reviewed papers, 20 book chapters, 6 co-authored books and 11 edited books.
  • Explores how the design of a range of nanomaterials make them effective theranostic agents, including multifunctional core-shell nanostructures, mesoporous silica nanoparticles, and quantum dots
  • Shows how nanomaterials are used effectively for a range of diseases, including breast cancer, prostate cancer and neurological disorders
  • Assesses the pros and cons of using different nanomaterials for different types of treatment

Date de parution :

Ouvrage de 692 p.

19x23.3 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

198,88 €

Ajouter au panier

Thèmes de Design of Nanostructures for Theranostics Applications :

Mots-clés :

ASO; Analytical characterization; Anatomical; Anti-tumor efficacy; Anticancer drugs; Aptamer; Biodegradable polymeric nanoparticles; Biomarker; Biomedical imaging; Biosensors; Block copolymer core-shell nanoparticles; Breast cancer; CRISPR; CRISPRa; CRISPRi; CRISPRn; CT; Cancer; Cancer cells; Cancer diagnostics; Cancer immunotherapy; Cancer theranostics; Cancer therapeutics; Cancer treatment; Cardiovascular diseases; Cas1; Cas2; Cas9; Chemotherapeutics; Controlled release; DCas9; Degradation; Dendrimer-drug conjugate; Dendrimers; Determination; Diagnosis; Drug delivery system; Drug delivery systems; Drug treatment; Epigenome therapy; Functional; Gene; Genomics; Gold; Green cage nanoparticles; Her2; Hormonal therapy; Hybrid systems; Imaging; Iron; Lipid-polymer hybrid nanoparticles; Lipopolyplexes; Liposomes; Lung cancer; MCM-41; MRI; MRS; Magnetic affinity beads; Mammography; Melanoma; Mesoporous silica; Metal-organic framework nanoparticles; MiRNA; Micelles; Molecular imaging; Monoclonal antibody; Multistage targeting; Nanocarriers; Nanochips; Nanodevices; Nanomedicine; Nanoneuromedicine; Nanoparticle; Nanoparticles; Nanotechnology; Nanotheranostics; Nanotoxicity; Oncology; PET; Photothermal and hyperthermia; Plastic surgery robotic therapy; Polymer-lipid hybrid core-shell nanoparticles; Polymer-polypeptide hybrid core-shell nanoparticles; Prevention; Prognosis; Prostate cancer; Proteomics; RNAi; SBA-15; SPECT; Self-assembly; ShRNA; SiRNA; Silver; Small RNA; Smart drug delivery carriers; Stability; Stimuli-responsive nanogels; Surface modification; Surgery